After a year of unprecedented health and economic challenges, the global economy is trying to recover, and the energy transition needs to be at the heart of this. As a lifeline out of the COVID-19 pandemic, the European Union has proposed the Green Deal, which focuses on achieving zero net emissions by 2050. Can oil and gas companies also lead the transition to a net-zero future in more traditional and heavily carbonized economies, such as Poland?

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the last part of which discusses other consequences of the pandemic not yet mentioned as well as sector barriers and suggested state actions.

The current political atmosphere in Poland is rather turbulent, according to Noerr Partner Radoslaw Biedecki, as the government is losing support and the opposition remains divided.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the third of which focuses on patients’ rights, the product market and an evaluation of the state’s actions during the pandemic.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the second of which concentrates on the impact of the pandemic on reimbursement and on the organisation of the healthcare system.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the first of which focuses on the overall impact of the pandemic as well as relations with healthcare professionals and clinical trials.

The database of rulings of Polish administrative courts already includes multiple ones related to entries into the Register of domains used to offer gambling games in contravention of the Polish Gambling Act ("Register").

Despite questions of political interference by the ruling party being raised in Poland, the Central European giant seems to be on a positive track, according to Penteris Partner Tomasz Kudelski.

The recent implementation of the AML V Directive to the Polish Act on Counteracting Money Laundering and Terrorist Financing will have a significant impact on business and the approach taken by state bodies to certain transactions. The main changes are as follows:

Jolanta Nowakowska-Zimoch has been named the new Managing Partner of Greenberg Traurig's Warsaw office. She will be supported by two new Deputy Managing Partners, Rafal Baranowski and Radomil Charzynski.

Krzysztof Mazurek has joined the Precision Medicine Group as its Deputy General Counsel and Head of Legal Europe. In his new role, he's also acting as Managing Director for CEE Precision Medicine Group Affiliates.

The challenges arising from the protection of personal data are countless and inescapable in our landscape. Three years after the GDPR came into force, some clear trends can be seen on the Polish market, from which a set of good enforcement practices may be derived.

Regional periodical league tables ranking M&A activity through the lens of the law firms advising on the deals are often dominated by Baltic law firms, with the CEELM Index special issue of the CEE Legal Matters magazine reflecting the same trend. To better understand why that is so, we spoke with several Partners – from both Baltic firms and other CEE jurisdictions.

Over the years, all countries in the CEE region have drawn best-practice models from the West, particularly in legal, economic, and business terms. In a number of CEE countries, offices of international law firms opened in response to the needs of their global clients and market opportunities. These firms played a significant role and introduced their know-how to the legal market. Parallel to this, strong local players emerged in each of these countries, changing the competitive environment and challenging the international ones. Over the last few years, you can see a revision of the need to maintain a presence in the region by some international law firms, most notably Magic Circle and White Shoe firms.

The new Polish restitution law has been enacted and signed by the President. It solves the problem of restitution claims by making a clean break and doing away with them altogether. But is that the end of the story?

While the Dealer’s Choice Conference in London could not be organized this year in a safe manner due to current events, on July 20, 2021, CEE Legal Matters sat down with several of the event’s sponsors to take a closer look at the Deals of the Year award winners this year.

On 11 August 2021 Polish Parliament enacted the Act amending the Code of Administrative Procedure which has been just published.

The COVID-19 pandemic has taken its toll on Poland, as it has on other European countries. In April, Poland recorded by far the biggest number of COVID-19 fatalities since the onset of the pandemic in March of last year. Consequently, most of the government’s plans to reform healthcare/pharmaceutical legislation have been either frozen or postponed. Most recent legislation has been aimed at legalizing the lockdown or enacting other pandemic measures, such as social distancing and mask-wearing in public spaces, as well as speeding up the vaccination rollout across the country. However, these new laws were essentially technical adjustments to the current framework, rather than revolutionary changes.